| Renal Non-Clear Cell Carcinoma studied in …STUDIED_INderived71 of 71show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981509Phase 2 · recruiting Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024680completed Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Unclassified Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252585Phase 4 · active not recruiting A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07816770Phase 2 · not yet recruiting MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411081Phase 2 · active not recruiting Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03595124Phase 2 · active not recruiting A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | TFE3-Rearranged Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444880Phase 2 · active not recruiting Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665361Phase 1/Phase 2 · recruiting Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413123Phase 2 · active not recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128680Phase 1 · recruiting Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339138completed Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447103Phase 2 · recruiting An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037004Phase 2 · recruiting Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043090Phase 3 · active not recruiting Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Kidney Oncocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06318871early Phase 1 · active not recruiting Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05347212Phase 2 · active not recruiting Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05808608Phase 1/Phase 2 · active not recruiting A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502716available Compassionate Use of Ubamatamab · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06453642NA · active not recruiting Evaluation of a Simple-Prep Controlled Embolic · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243067not yet recruiting Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623502NA · recruiting An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875548Phase 1/Phase 2 · completed A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805825Phase 1 · recruiting A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302569Phase 2 · recruiting Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03685448Phase 2 · completed ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601950Phase 2 · completed A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537715Phase 1 · completed Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761057Phase 2 · completed Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211114Phase 2 · recruiting Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620134Phase 1/Phase 2 · active not recruiting Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399419Phase 1 · recruiting CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146777Phase 3 · not yet recruiting Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068393Phase 2 · completed Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603365Phase 2 · withdrawn Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02654340terminated Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489695Phase 2 · completed Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · condition mapped CURATED_BROADER · 71 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05372302unknown Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126672Phase 2 · completed RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177239Phase 2 · unknown Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03525834Phase 4 · completed Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Kidney Angiomyolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03354884Phase 2 · completed caBozantinib in cOllectiNg ductS Renal Cell cArcInoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02127710Phase 2 · completed A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) · condition mapped ALIAS · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02363751Phase 2 · completed Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Collecting Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02837991Phase 1 · terminated A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027820Phase 1/Phase 2 · completed Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688973Phase 2 · completed Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01727089Phase 2 · completed Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335556Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098618Phase 2 · terminated Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 71 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |